1. Abukhdeir AM, Park BH . (2008). P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med 10: e19.
2. Alle KM, Henshall SM, Field AS, Sutherland RL . (1998). Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin Cancer Res 4: 847–854.
3. Ariazi EA, Ariazi JL, Cordera F, Jordan VC . (2006). Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem 6: 181–202.
4. Barker S . (2003). Anti-estrogens in the treatment of breast cancer: current status and future directions. Curr Opin Investig Drugs 4: 652–657.
5. Borg A, Zhang QX, Alm P, Olsson H, Sellberg G . (1992). The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 52: 2991–2994.